Two Sigma Securities, LLC Vaxart, Inc. Transaction History

Two Sigma Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.53 - $1.3 $2,583 - $6,337	4,875 Added 47.65%	15,105 $10,000
Q1 2024 May 15, 2024	SELL	$0.56 - $1.41 $21,938 - $55,236	-39,175 Reduced 79.29%	10,230 $13,000
Q4 2023 Feb 14, 2024	SELL	$0.57 - $0.85 $13,946 - $20,797	-24,468 Reduced 33.12%	49,405 $28,000
Q3 2023 Nov 14, 2023	BUY	$0.69 - $0.85 $5,548 - $6,835	8,042 Added 12.22%	73,873 $55,000
Q2 2023 Aug 14, 2023	BUY	$0.6 - $1.41 $39,498 - $92,821	65,831 New	65,831 $48,000
Q4 2022 Feb 14, 2023	BUY	$0.75 - $2.24 $8,197 - $24,483	10,930 Added 97.25%	22,169 $21,000
Q3 2022 Nov 14, 2022	SELL	$2.09 - $4.5 $4,840 - $10,422	-2,316 Reduced 17.09%	11,239 $25,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $5.28 $7,786 - $15,227	-2,884 Reduced 17.54%	13,555 $47,000
Q1 2022 May 16, 2022	BUY	$4.29 - $6.64 $70,523 - $109,154	16,439 New	16,439 $83,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.